The stock of Geron Corp (NASDAQ:GERN) last traded at $1.34, up 1.52% from the previous session.
GERN stock price is now -6.16% away from the 50-day moving average and -48.93% away from the 200-day moving average. The market capitalization of the company currently stands at $853.47M.
On May 08, 2025, Scotiabank Downgraded its previous ‘Sector Outperform’ rating to ‘Sector Perform’ on the stock keeping its target price maintained at $1.50, while ‘B. Riley Securities’ rates the stock as ‘Neutral’
In other news, LAWLIS V BRYAN, Director bought 13,300 shares of the company’s stock on May 09 ’25. The stock was bought for $15,667 at an average price of $1.18. Upon completion of the transaction, the Director now directly owns 13,300 shares in the company, valued at $17822.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 27 ’25, EVP, Chief Legal Officer Samuels Scott Alan bought 15,000 shares of the business’s stock. A total of $24,150 was incurred on buying the stock at an average price of $1.61. This leaves the insider owning 26,682 shares of the company worth $35753.88. A total of 5.26% of the company’s stock is owned by insiders.
During the past 12 months, Geron Corp has had a low of $1.17 and a high of $5.06. As of last week, the company has a debt-to-equity ratio of 0.92, a current ratio of 7.87, and a quick ratio of 6.97. The fifty day moving average price for GERN is $1.428 and a two-hundred day moving average price translates $2.6237 for the stock.
The latest earnings results from Geron Corp (NASDAQ: GERN) was released for 2025-03-31. The net profit margin was -119.54% and return on equity was -45.35% for GERN. The company reported revenue of $39.6 million for the quarter, compared to $0.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12927.3 percent.
